Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ali Rahmy
Early CT and FDG-metabolic Tumour Volume Changes Show a Significant Correlation With Survival in Stage I–III Small Cell Lung Cancer: A Hypothesis Generating Study
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
Related publications
Prognostic Value of SUVmax and Metabolic Tumor Volume on 18f-FDG PET/CT in Early Stage Non-Small Cell Lung Cancer Patients Without LN Metastasis
Bio-Medical Materials and Engineering
Medicine
Biomaterials
Biomedical Engineering
Applicability of a Prognostic CT-based Radiomic Signature Model Trained on Stage I-Iii Non-Small Cell Lung Cancer in Stage IV Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Prognositc Significance of SUVmaxon Pretreatment18F-FDG PET/CT in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy: A Meta-Analysis
Journal of Medical Imaging and Radiation Oncology
Oncology
Radiology
Nuclear Medicine
Imaging
Social Factors, Treatment, and Survival in Early-Stage Non-Small Cell Lung Cancer.
American Journal of Public Health
Environmental
Public Health
Occupational Health
FDG Uptake on Positron Emission Tomography Correlates With Survival and Time to Recurrence in Patients With Stage I Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.16-42 Early Stage Non-Small Cell Lung Cancer Survival in a Chilean Private Teaching Hospital
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Survival After Segmentectomy and Wedge Resection in Stage I Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Nomogram for the Prediction of Overall Survival in Patients With Stage II and III Non‑small Cell Lung Cancer Using a Population‑based Study
Oncology Letters
Cancer Research
Oncology
Prognostic Factors in Stage III Non-Small Cell Lung Cancer: A Review of Conventional, Metabolic and New Biological Variables
Therapeutic Advances in Medical Oncology
Oncology
